Those who invested in Malaysian Pacific Industries Berhad (KLSE:MPI) five years ago are up 96%
When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying the right stocks can give your wealth a significant boost. For example, long term Malaysian Pacific Industries Berhad (KLSE:MPI) shareholders have enjoyed a 85% share price rise over the last half decade, well in excess of the market return of around 6.6% (not including dividends).
So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
Over half a decade, Malaysian Pacific Industries Berhad managed to grow its earnings per share at 6.6% a year. This EPS growth is lower than the 13% average annual increase in the share price. So it's fair to assume the market has a higher opinion of the business than it did five years ago. And that's hardly shocking given the track record of growth.
The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).
We know that Malaysian Pacific Industries Berhad has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.
When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, Malaysian Pacific Industries Berhad's TSR for the last 5 years was 96%, which exceeds the share price return mentioned earlier. This is largely a result of its dividend payments!
While the broader market lost about 7.2% in the twelve months, Malaysian Pacific Industries Berhad shareholders did even worse, losing 47% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. On the bright side, long term shareholders have made money, with a gain of 14% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Malaysian Pacific Industries Berhad has 1 warning sign we think you should be aware of.
If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges.
—
Investing narratives with Fair Values
Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor
Fair Value Estimated: A$2.42 · 0.1% Overvalued
Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor
Fair Value Estimated: €78.41 · 0.1% Overvalued
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor
Fair Value Estimated: $325.55 · 0.6% Undervalued
View more featured narratives
—
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
38 minutes ago
- Bloomberg
Medtech Brainlab, Holders Seek €400 Million in Frankfurt IPO
Medical technology software firm Brainlab AG and its shareholders are seeking up to €400 million ($460 million) in its Frankfurt initial public offering, as several European companies look to list ahead of the typical summer holiday break. The offering is expected to consist of shares being offered at €80 to €100 apiece, according to a Monday statement. The Munich-based company is planning to offer two million new shares, while holders including founder Stefan Vilsmeier are looking to offer up to two million shares as well.


Bloomberg
an hour ago
- Bloomberg
Walmart's PhonePe Is Said to Seek $1.5 Billion for India IPO
By and Baiju Kalesh Save Walmart Inc. 's PhonePe, India's largest provider of digital payments, is preparing to file preliminary documents for an initial public offering that may raise as much as $1.5 billion, according to people familiar with the matter. The deal would value the fintech company at about $15 billion, and PhonePe is planning to submit a draft red herring prospectus for the listing by as early as August, the people said, asking not to be identified because the information is private.


Bloomberg
an hour ago
- Bloomberg
Buyout Firm Advent Agrees to £3.8 Billion Deal for UK's Spectris
Buyout firm Advent reached an agreement to buy Spectris Plc, a UK maker of precision and testing equipment and software, for about £3.8 billion ($5.1 billion). Advent is offering £37.63 in cash, which includes a proposed interim dividend of £0.28 per share, according to a statement on Monday. Spectris's directors deem the offer as 'fair and reasonable' and plan to unanimously recommend the offer to shareholders, they said.